Amgen
Amgen is seeking a Senior Scientist to expand pre-clinical oligonucleotide conjugation capabilities within the Genetic Medicines team. The role involves designing, synthesizing, purifying, and characterizing protein-oligonucleotide, small molecule-oligonucleotide, and peptide-oligonucleotide conjugates to support siRNA-based therapeutics. Candidates will serve as subject-matter experts, collaborate with cross-functional teams, and prepare research results for patents and publications.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
6% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Research Associate/Senior Research Associate, Oligonucleotide Chemistry
Korro Bio
Research Associate II, Oligonucleotide Synthesis
CRISPR Therapeutics
Senior Associate Scientist Oncology United States
alnylam
Director, Chemistry, Next Generation Genetic Medicine
Ignite Human Capital
Senior Scientist, Protein and Antibody Bioconjugation
lifelancer
Principal Scientist, Oligonucleotide Chemistry Research
Neurocrine Biosciences